Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

Educated Patient® Kidney Cancer Summit Combination Therapy Panel: April 9, 2022 This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter.

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

This panel was moderated by Kristie L. Kahl and featured Dr. Thomas Hutson, Louise Gunter and Meryl Uranga. Kahl: I want to shift gears to managing side effects, and also the importance of ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

An expert panel of US nephrologists and other health care providers unanimously agreed that secondary hyperparathyroidism treatment is often started too late in patients with chronic kidney disease. A ...

Medtronic suffered yet another disappointment in its relentless pursuit of bringing renal denervation to market for people living with uncontrolled high blood pressure. There seems to be no question ...

Standardizing follow-up after kidney stone treatment may reduce ionizing radiation exposure, identify recurrences earlier, and avoid complications such as urosepsis and chronic kidney disease, ...

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel has deemed the ReCor Paradise Ultrasound Renal Denervation (uRDN) System safe and effective in lowering blood pressure ...